CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
Clinical trial NCT01243424 · COMPLETED
Trial details
- NCT number
- NCT01243424
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-11
- Primary completion
- 2018-08-21
- Enrollment
- 6103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.